Europe Artificial Intelligence in Healthcare Diagnosis Market Growth and Forecast by 2027

Historic Data: 2017-2018   |   Base Year: 2019   |   Forecast Period: 2020-2027

Europe Artificial Intelligence in Healthcare Diagnosis Market Forecast to 2027 - COVID-19 Impact and Regional Analysis by Diagnostic Tool (Medical Imaging Tool, Automated Detection System, and Others); Application (Eye Care, Oncology, Radiology, Cardiovascular, and Others); End User (Hospital and Clinic, Diagnostic Laboratory, and Home Care); Service (Tele-Consultation, Tele Monitoring, and Others); and Country

  • Report Code : TIPRE00013354
  • Category : Technology, Media and Telecommunications
  • No. of Pages : 125
Buy Now

The artificial intelligence in healthcare diagnosis market in Europe is expected to grow from US$ 897.23 million in 2019 to US$ 16,228.63 million by 2027. This represents a CAGR of 43.8% from 2020 to 2027.

The growth of the market in the region is expected to grow owing to rising adoption of Artificial Intelligence (AI) in disease identification and diagnosis, increasing investment in AI healthcare start-ups are projected to drive the Europe artificial intelligence in healthcare diagnosis market during the forecast period.

The UK has observed fast growth in the artificial intelligence in healthcare diagnosis market within the past few years and is expected to lead the market in Europe during the forecast period. The healthcare industry has always been a leader in innovation. The constant mutating of diseases and viruses makes it difficult to stay ahead of the curve. However, with the help of artificial intelligence and machine learning algorithms, it continues to advance, creating new treatments and helping people live longer and healthier. A study published by The Lancet Digital Health compared the performance of deep learning a form of artificial intelligence (AI) in detecting diseases from medical imaging versus that of healthcare professionals, using a sample of studies carried out between 2012 and 2019. The study found that, in the past few years, AI has become more precise in identifying disease diagnosis in these images and has become a more feasible source of diagnostic information. With advancements in AI, deep learning may become even more efficient in identifying diagnosis in the coming years. Moreover, it can help doctors with diagnoses and notify when patients are weakening so that the medical intervention can occur sooner before the patient needs hospitalization. It can save costs for both the hospitals and patients. Additionally, the precision of machine learning can detect diseases such as cancer quickly, thus saving lives.


UK Artificial Intelligence in Healthcare Diagnosis Market Revenue and Forecast to 2027 (US$ Million)

UK Artificial Intelligence in Healthcare Diagnosis Market Revenue and Forecast to 2027 (US$ Million)

  • This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

EUROPE ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS – MARKET SEGMENTATION

By Diagnostic Tool

  • Medical Imaging Tool
  • Automated Detection System
  • Others

By Application

  • Eye Care
  • Oncology
  • Radiology
  • Cardiovascular
  • Others

By Service

  • Tele-Consultation
  • Tele Monitoring
  • Others

By End User

  • Hospitals and Clinics
  • Diagnostic Laboratory
  • Home Care
    • Doctors
    • Patients

By Country

  • China
  • Japan
  • India
  • South Korea
  • Australia

Company Profiles

  • General Electric Company
  • Koninklijke Philips N.V.
  • Aidoc, Arterys Inc.
  • Icometrix, IDx Technologies Inc.
  •  MaxQ AI Ltd.
  • Caption Health, Inc.
  • Zebra Medical Vision, Inc.
  • Siemens Healthcare Private Limited

Europe Artificial Intelligence in Healthcare Diagnosis Report Scope

Report Attribute Details
Market size in 2019 US$ 897.23 Million
Market Size by 2027 US$ 16,228.63 Million
Global CAGR (2020 - 2027) 43.8%
Historical Data 2017-2018
Forecast period 2020-2027
Segments Covered By Diagnostic Tool
  • Medical Imaging Tool
  • Automated Detection System
By Application
  • Eye Care
  • Oncology
  • Radiology
  • Cardiovascular
By End User
  • Hospital and Clinic
  • Diagnostic Laboratory
  • Home Care
By Service
  • Tele-Consultation
  • Tele Monitoring
Regions and Countries Covered Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Market leaders and key company profiles
  • General Electric Company
  • Koninklijke Philips N.V.
  • Aidoc, Arterys Inc.
  • Icometrix, IDx Technologies Inc.
  • MaxQ AI Ltd.
  • Caption Health, Inc.
  • Zebra Medical Vision, Inc.
  • Siemens Healthcare Private Limited
    • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
    • PEST and SWOT Analysis
    • Market Size Value / Volume - Global, Regional, Country
    • Industry and Competitive Landscape
    • Excel Dataset
    europe-artificial-intelligence-in-healthcare-diagnosis-market-report-deliverables-img1
    europe-artificial-intelligence-in-healthcare-diagnosis-market-report-deliverables-img2
    Report Coverage

    Report Coverage

    Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

    Segment Covered

    Segment Covered

    Diagnostic Tool, Application, End User, Service, and Country

    Regional Scope

    Regional Scope

    North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

    Country Scope

    Country Scope

    UK, Germany, France, Italy, Russia

    Trends and growth analysis reports related to Technology, Media and Telecommunications : READ MORE..   

    Europe Artificial Intelligence in Healthcare Diagnosis Market
    Connect With Expert
    1. General Electric Company
    2. Koninklijke Philips N.V.
    3. Aidoc, Arterys Inc.
    4. Icometrix, IDx Technologies Inc.
    5.  MaxQ AI Ltd.
    6. Caption Health, Inc.
    7. Zebra Medical Vision, Inc.
    8. Siemens Healthcare Private Limited
    europe-artificial-intelligence-in-healthcare-diagnosis-market-cagr